The New Infrastructure of Biotech Entrepreneurship

The New Infrastructure of Biotech Entrepreneurship

Building a biotech company no longer means building everything yourself.

Today’s founders are navigating a growing ecosystem of shared labs, CROs, fractional teams, AI-enabled tools, accelerators, and strategic partners that are changing how early-stage biotech companies get built.

This session explores the new infrastructure of biotech entrepreneurship and how founders can leverage external resources to move faster, stay capital-efficient, and focus internal teams on the science and capabilities that matter most.

You’ll Learn

• What early-stage biotech companies should build in-house vs. outsource

• How shared infrastructure is changing the cost of starting a biotech company

• When to leverage CROs, fractional teams, and strategic partners

• How founders can scale without building unnecessary infrastructure too early

• How community and founder networks can accelerate company building, problem-solving, and access to resources

• How to create ecosystems that bring scientists, founders, and operators together to build trust, exchange ideas, and spark meaningful collaborations

Who Should Attend?

• Pre-seed through Series A+ biotech founders

• Scientists exploring commercialization

• Startup operators and technical leaders

• Investors and venture partners

• Biotech service providers and ecosystem partners

Hosted by MelanInScience as part of the BioInnovation Series during SF Tech Week.